48,830
edits
Line 11: | Line 11: | ||
**Discouraged... as the cervix remains and can develop a cancer. | **Discouraged... as the cervix remains and can develop a cancer. | ||
*Total hysterectomy. | *Total hysterectomy. | ||
**Indications: | **Indications: | ||
***Endometrial cancer (low stage, good histologic type), [[endometrial hyperplasia]]. | |||
***[[Uterine prolapse]]. | |||
***[[Uterine adenomyosis]]. | |||
***[[Uterine leiomyoma]]s. | |||
***Chronic pelvic pain.<ref name=pmid21508759>{{Cite journal | last1 = Lamvu | first1 = G. | title = Role of hysterectomy in the treatment of chronic pelvic pain. | journal = Obstet Gynecol | volume = 117 | issue = 5 | pages = 1175-8 | month = May | year = 2011 | doi = 10.1097/AOG.0b013e31821646e1 | PMID = 21508759 }}</ref> | |||
*Radical hysterectomy - total hysterectomy + parametrial tissue.<ref name=pmid19546764>{{Cite journal | last1 = Frumovitz | first1 = M. | last2 = Sun | first2 = CC. | last3 = Schmeler | first3 = KM. | last4 = Deavers | first4 = MT. | last5 = Dos Reis | first5 = R. | last6 = Levenback | first6 = CF. | last7 = Ramirez | first7 = PT. | title = Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. | journal = Obstet Gynecol | volume = 114 | issue = 1 | pages = 93-9 | month = Jul | year = 2009 | doi = 10.1097/AOG.0b013e3181ab474d | PMID = 19546764 }}</ref> | *Radical hysterectomy - total hysterectomy + parametrial tissue.<ref name=pmid19546764>{{Cite journal | last1 = Frumovitz | first1 = M. | last2 = Sun | first2 = CC. | last3 = Schmeler | first3 = KM. | last4 = Deavers | first4 = MT. | last5 = Dos Reis | first5 = R. | last6 = Levenback | first6 = CF. | last7 = Ramirez | first7 = PT. | title = Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. | journal = Obstet Gynecol | volume = 114 | issue = 1 | pages = 93-9 | month = Jul | year = 2009 | doi = 10.1097/AOG.0b013e3181ab474d | PMID = 19546764 }}</ref> | ||
**Indications: cervical cancers, advanced uterine cancers. | **Indications: cervical cancers, advanced uterine cancers. |
edits